Evidence map›Paper›PMID 33953977›Full record

ArticleJournal of nutrition and metabolism2021

Effect of a High-Protein High-Fibre Nutritional Supplement on Lipid Profile in Overweight/Obese Adults with Type 2 Diabetes Mellitus: A 24-Week Randomized Controlled Trial.

Rachana Bhoite, Anitha Chandrasekaran, Varalakshmi Lalithya Pratti, Vinita Satyavrat, Shivani Aacharya, Amey Mane, Suyog Mehta, Ravindra Machhindra Kale, Gayathri Nagamuthu, Sasikala Selvaraj and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of nutrition and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Optimizing Nutrition Strategies for Diabetes Management in India: An Expert Opinion.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Rachana BhoiteDr. Reddy's Laboratories Pvt Ltd., Ameerpet, Hyderabad, India.ORCID https://orcid.org/0000-0001-5291-6799
Anitha ChandrasekaranDepartment of Diabetology, Dr. Mohan's Diabetes Specialities Centre, Chennai, India.
Varalakshmi Lalithya PrattiDr. Reddy's Laboratories Pvt Ltd., Ameerpet, Hyderabad, India.
Vinita SatyavratDr. Reddy's Laboratories Pvt Ltd., Ameerpet, Hyderabad, India.
Shivani AacharyaDr. Reddy's Laboratories Pvt Ltd., Ameerpet, Hyderabad, India.
Amey ManeDr. Reddy's Laboratories Pvt Ltd., Ameerpet, Hyderabad, India.
Suyog MehtaDr. Reddy's Laboratories Pvt Ltd., Ameerpet, Hyderabad, India.
Ravindra Machhindra KaleDr. Reddy's Laboratories Pvt Ltd., Ameerpet, Hyderabad, India.
Gayathri NagamuthuDepartment of Foods, Nutrition & Dietetics Research, Madras Diabetes Research Foundation, Chennai, India.
Sasikala SelvarajDepartment of Foods, Nutrition & Dietetics Research, Madras Diabetes Research Foundation, Chennai, India.
Gayathri RajagopalDepartment of Foods, Nutrition & Dietetics Research, Madras Diabetes Research Foundation, Chennai, India.
Sudha VasudevanDepartment of Foods, Nutrition & Dietetics Research, Madras Diabetes Research Foundation, Chennai, India.
Shobana ShanmugamDepartment of Foods, Nutrition & Dietetics Research, Madras Diabetes Research Foundation, Chennai, India.
Anjana Ranjit MohanDepartment of Diabetology, Dr. Mohan's Diabetes Specialities Centre, Chennai, India.
Ranjit UnnikrishnanDepartment of Diabetology, Dr. Mohan's Diabetes Specialities Centre, Chennai, India.
Kamala KrishnaswamyDepartment of Foods, Nutrition & Dietetics Research, Madras Diabetes Research Foundation, Chennai, India.
Viswanathan MohanDepartment of Diabetology, Dr. Mohan's Diabetes Specialities Centre, Chennai, India.
Madras Diabetes Research Foundation · INDr. Reddy's Laboratories (India) · INDr. Mohan's Diabetes Specialities Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFoods rich in protein and dietary fibre could potentially improve lipid profile in overweight or obese diabetic patients with dyslipidemia and, thereby, mitigate their risk of cardiovascular disease (CVD). In this study, the effect of providing high-protein high-fibre (HPHF) nutritional supplement in addition to standard care of type 2 diabetes mellitus (T2DM) on lipid profile was evaluated.

methodsIn this open-label, parallel-arm, prospective, randomized study, a total of 100 overweight/obese participants with T2DM were randomized to either an intervention group (25 g HPHF nutritional supplement given twice daily along with a standard care of T2DM) or a control group (standard care of T2DM) for 24 weeks. Change from baseline in lipid parameters such as total cholesterol (TChol), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) was assessed between the intervention and control group at week 12 and week 24. Participant compliance was assessed using the dietary 24-hour recall. Statistical analysis was performed to assess the main effects on within- and between-group changes from baseline to end of 24 weeks.

resultsParticipants in the HPHF nutritional supplement group showed a statistically significant improvement in HDL-C levels by the end of 24 weeks (

conclusionTwice-daily consumption of a HPHF nutritional supplement significantly improved HDL-C levels. Inclusion of the HPHF supplement would be a useful effective aid for managing dyslipidemia in overweight/obese individuals with T2DM.

Identifiers

PMID33953977
PMCPMC8064784
OpenAlexW3153211294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.